Skip to main content

Table 2 Demographics of patients and clinical data

From: The R.I.R.S. scoring system: An innovative scoring system for predicting stone-free rate following retrograde intrarenal surgery

 

No. of patients

SF

Non-SF

P value

No. of patients (%)

382

281 (73.6%)

101 (26.4%)

 

Gender

   

0.017*

 Male

256 (67.0%)

198 (77.3%)

58 (22.7%)

 

 Female

126 (33.0%)

83 (65.9%)

43 (34.1%)

 

Age (yo)

51.93 ± 12.32

52.14 ± 12.19

51.37 ± 12.74

0.590a

Hypertention

   

0.069

 Yes

120 (31.4%)

81 (67.5%)

39 (32.5%)

 

 No

262 (68.6%)

200 (76.3%)

62 (23.7%)

 

Diabetes mellitus

   

0.030*

 Yes

36 (9.4%)

21 (57.3%)

15 (41.7%)

 

 No

346 (90.6%)

260 (75.1%)

86 (24.9%)

 

 BMI (kg/m2)

21.68 (23.79–19.1; 4.69)

21.57 (23.63–19.13; 4.50)

22.07 (24.29–19.08; 5.21)

0.406b

History of surgery

   

0.064

 SWL

13 (3.4%)

11 (84.6%)

2 (15.4%)

 

 URL or RIRS

36 (9.4%)

22 (61.1%)

14 (38.9%)

 

 PNL

29 (7.6%)

16 (55.2%)

13 (44.8%)

 

 Laparoscopic ureterolithotomy

15 (3.9%)

13 (86.7%)

2 (13.3%)

 

 Pyuloplasty

3 (0.8%)

1 (33.3%)

2 (66.7%)

 

 Open surgery

3 (0.8%)

2 (66.7%)

1 (33.3%)

 

 No

294 (77.0%)

223 (75.9%)

71 (24.1%)

 

UAS

   

0.927

 Yes

373 (97.6%)

275 (73.7%)

98 (26.3%)

 

 No

9 (2.4%)

6 (66.7%)

3 (33.3%)

 

Relocation

   

0.317

 In situ

346 (90.6%)

252 (72.8%)

94 (27.2%)

 

 Ex situ

36 (9.4%)

29 (80.6%)

7 (19.4%)

 

Duration of procedure (min)

50 (60–40; 20)

50 (60–40; 20)

60 (85–50; 35)

<0.001b*

Hospitalization (days)

5 (7–4; 3)

5 (6–3; 3)

6 (7–4; 3)

<0.001b*

Complications

   

0.008*

 Yes

27 (7.1%)

14 (51.9%)

13 (48.1%)

 

 No

335 (92.9%)

267 (75.2%)

88 (24.8%)

 
  1. *Statistical significance was set at P < 0.05
  2. UAS: Ureteral Access Sheath
  3. aStudent’s t test, b Mann-Whitney U test